ASP Isotopes (ASPI) Competitors $4.78 -0.13 (-2.55%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.74 -0.03 (-0.63%) As of 02/21/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ASPI vs. UAN, TROX, ECVT, WLKP, OEC, ASIX, VHI, LXFR, SLI, and ARQShould you be buying ASP Isotopes stock or one of its competitors? The main competitors of ASP Isotopes include CVR Partners (UAN), Tronox (TROX), Ecovyst (ECVT), Westlake Chemical Partners (WLKP), Orion (OEC), AdvanSix (ASIX), Valhi (VHI), Luxfer (LXFR), Standard Lithium (SLI), and ARQ (ARQ). These companies are all part of the "chemicals" industry. ASP Isotopes vs. CVR Partners Tronox Ecovyst Westlake Chemical Partners Orion AdvanSix Valhi Luxfer Standard Lithium ARQ ASP Isotopes (NASDAQ:ASPI) and CVR Partners (NYSE:UAN) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk, profitability and community ranking. Does the media refer more to ASPI or UAN? In the previous week, CVR Partners had 8 more articles in the media than ASP Isotopes. MarketBeat recorded 11 mentions for CVR Partners and 3 mentions for ASP Isotopes. CVR Partners' average media sentiment score of 0.80 beat ASP Isotopes' score of 0.44 indicating that CVR Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVR Partners 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ASPI or UAN? CVR Partners received 206 more outperform votes than ASP Isotopes when rated by MarketBeat users. However, 100.00% of users gave ASP Isotopes an outperform vote while only 59.50% of users gave CVR Partners an outperform vote. CompanyUnderperformOutperformASP IsotopesOutperform Votes7100.00% Underperform VotesNo VotesCVR PartnersOutperform Votes21359.50% Underperform Votes14540.50% Do institutionals and insiders believe in ASPI or UAN? 16.8% of ASP Isotopes shares are owned by institutional investors. Comparatively, 43.8% of CVR Partners shares are owned by institutional investors. 21.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, ASPI or UAN? CVR Partners has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than CVR Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASP Isotopes$430K792.76-$16.29M-$0.61-7.83CVR Partners$525.32M2.60$172.43M$5.7613.85 Which has more volatility and risk, ASPI or UAN? ASP Isotopes has a beta of 3.51, indicating that its stock price is 251% more volatile than the S&P 500. Comparatively, CVR Partners has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Do analysts recommend ASPI or UAN? ASP Isotopes currently has a consensus price target of $4.50, indicating a potential downside of 5.76%. Given ASP Isotopes' stronger consensus rating and higher probable upside, equities analysts clearly believe ASP Isotopes is more favorable than CVR Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASP Isotopes 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00CVR Partners 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ASPI or UAN more profitable? CVR Partners has a net margin of 11.59% compared to ASP Isotopes' net margin of -807.39%. CVR Partners' return on equity of 20.56% beat ASP Isotopes' return on equity.Company Net Margins Return on Equity Return on Assets ASP Isotopes-807.39% -123.83% -51.58% CVR Partners 11.59%20.56%6.26% SummaryCVR Partners beats ASP Isotopes on 11 of the 18 factors compared between the two stocks. Get ASP Isotopes News Delivered to You Automatically Sign up to receive the latest news and ratings for ASPI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASPI vs. The Competition Export to ExcelMetricASP Isotopeschemical products IndustryMaterials SectorNASDAQ ExchangeMarket Cap$340.89M$1.60B$3.11B$8.95BDividend YieldN/A1.32%5.15%3.85%P/E Ratio-7.8321.57103.9818.81Price / Sales792.76612.1225,886,820,843,820,000.0076.66Price / CashN/A74.6624.3737.47Price / Book12.245.324.934.64Net Income-$16.29M$65.82M$152.38M$245.69M7 Day Performance-9.74%-5.82%-0.55%-2.63%1 Month Performance-25.39%-8.14%2.36%-2.37%1 Year Performance54.03%50.64%33.03%13.64% ASP Isotopes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASPIASP Isotopes0.6611 of 5 stars$4.78-2.6%$4.50-5.8%+54.0%$340.89M$430,000.00-7.8376UANCVR Partners2.9935 of 5 stars$77.61+1.1%N/A+13.2%$1.33B$681.48M15.62300Earnings ReportDividend IncreaseAnalyst DowngradeNews CoverageTROXTronox4.2292 of 5 stars$7.81-10.8%$16.00+105.0%-47.1%$1.23B$2.85B-16.266,500Dividend AnnouncementAnalyst ForecastHigh Trading VolumeECVTEcovyst4.2009 of 5 stars$8.22+0.2%$10.25+24.8%-16.6%$957.13M$691.10M17.86880News CoverageWLKPWestlake Chemical Partners3.8871 of 5 stars$23.64+0.4%N/A+9.7%$833.07M$1.19B13.51150Positive NewsHigh Trading VolumeOECOrion4.0703 of 5 stars$14.42+1.5%$23.50+63.0%-36.2%$832.38M$1.89B27.211,650Earnings ReportAnalyst ForecastNews CoverageASIXAdvanSix4.4833 of 5 stars$29.68-0.2%$39.50+33.1%+9.2%$793.32M$1.53B21.051,450Earnings ReportNews CoverageVHIValhi1.4959 of 5 stars$19.62+1.0%$20.00+1.9%+49.3%$555.30M$1.92B6.292,196News CoverageLXFRLuxfer3.424 of 5 stars$14.21-3.4%N/A+80.2%$380.54M$405M43.061,400Upcoming EarningsAnalyst UpgradeSLIStandard Lithium2.1894 of 5 stars$1.50-2.6%$3.95+163.3%N/A$259.13MN/A2.54N/AARQARQ2.6517 of 5 stars$5.91+1.4%$9.50+60.7%+64.2%$248.40M$99.18M-591.00140 Related Companies and Tools Related Companies CVR Partners Alternatives Tronox Alternatives Ecovyst Alternatives Westlake Chemical Partners Alternatives Orion Alternatives AdvanSix Alternatives Valhi Alternatives Luxfer Alternatives Standard Lithium Alternatives ARQ Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ASPI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASP Isotopes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ASP Isotopes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.